Cellulose nanofibrils and silver nanowires active coatings for the development of antibacterial packaging surfaces

An active ink composed of cellulose nanofibrils and silver nanowires was deposited on flexible and transparent polymer films using the bar coating process, achieving controlled thicknesses ranging from 200 nm up to 2 µm. For 350 nm thick coating on polyethylene terephthalate films, high transparency (75.6% transmittance) and strong reduction of bacterial growth equal to 89.3% and 100% was noted respectively against Gram-negative Escherichia Coli and Gram-positive Staphylococcus Aureus bacteria using AATCC contact active standard test. Retained antibacterial activity was found with films produced by reverse gravure roll-to-roll process, showing the promising capability of this antibacterial solution to be deployed industrially. Finally, the same ink was also deposited on polylactic acid substrate to investigate barrier properties: for 350 nm thick coating, a reduction of 49% of oxygen transmission rate (dry conditions) and 47% reduction of water vapor transmission rate was noted, proving the enhanced barrier properties of the coatings

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely